highly significantP < 0.001
The TG genotype in patients shows a highly significant difference from controls (odds ratio [OR], 2.104; [CI], 95% (1.406-3.147); P < 0.001), increasing the risk of NSCLC in comparison with the TT genotype (wild type).
The TG genotype in patients shows a highly significant difference from controls (odds ratio [OR], 2.104; [CI], 95% (1.406-3.147); P < 0.001), increasing the risk of NSCLC in comparison with the TT genotype (wild type).